Company news
Protokinetix, Inc. (OTC:PKTX) news
Protokinetix, Inc. news releases on 6ix. Latest, Jun 16, 2016: ProtoKinetix Completes Non-Brokered Private Placement & Secures Operating Line of Credit
Press releases — page 2
ProtoKinetix Completes Non-Brokered Private Placement & Secures Operating Line of Credit
June 16, 2016
ProtoKinetix’ AAGP™ has been Published in the Journal of Tissue Engineering and Regenerative Medicine
June 7, 2016
ProtoKinetix Updates Progress Toward Clinical Trial Application for AAGP™
May 12, 2016
AAGP™ Improves Results in Stem Cells Transplanted in Retina Tissue by 300%
May 2, 2016
ProtoKinetix Outlines Steps to Clinical Trial Application for AAGP™
April 26, 2016
ProtoKinetix Corporate Update
January 5, 2016
AAGP™ Found to Significantly Improve Islet Cell Transplantation in Type 1 Diabetes Patients
December 17, 2015
ProtoKinetix Completes Private Placement
November 9, 2015
ProtoKinetix Begins Testing Diabetic Mice with AAGP™ at the University of Alberta
September 18, 2015
ProtoKinetix’ AAGP™ to Be Presented at the Congress of the International Pancreas and Islet Transplant Association
September 10, 2015
ProtoKinetix Reports on Its Strong Collaboration with the James Shapiro Laboratory at the University of Alberta
August 4, 2015
ProtoKinetix Announces Appointment of New Director and Provides Corporate Update
July 1, 2015
ProtoKinetix Upgrades to OTCQB
June 8, 2015
CEO Clarence Smith Reports on Edmonton Meetings with Dr. James Shapiro and his Team
June 5, 2015
OTC Markets Group Welcomes Newly Verified OTCQB Companies – June 5
June 5, 2015
British Columbia Securities Commission - Cease Trade Order
May 9, 2013
Revocation of Cease Trade Order
January 22, 2009
Cease Trade Order
January 20, 2009